Hm. Ockenfels et al., TYROSINE PHOSPHORYLATION IN PSORIATIC T-CELLS IS MODULATED BY DRUGS THAT INDUCE OR IMPROVE PSORIASIS, Dermatology, 191(3), 1995, pp. 217-225
Background: The induction of protein tyrosine kinases (PTKs) is known
to be a key element in the activation of lymphocytes. Objective: Becau
se immunologic mechanisms are important in the pathogenesis of psorias
is, we examined the time course of tyrosine-phosphorylated proteins (p
-tyr) as a marker for cellular PTK activity in phytohemagglutinin (PHA
)-stimulated T cells of psoriatic patients and healthy controls. Metho
ds and Results: PHA-stimulated T cells from both groups expressed peak
s of p-tyr after 15 min and 4 h. In T cells from psoriatics, the 15-mi
n peak. was smaller but the 4-hour peak reached an enormous maximum, w
hich was 270% higher than the basic p-tyr value. PHA-stimulated T cell
s were additionally treated with psoriasis-provoking drugs (lithium, c
hloroquine, propranolol and ethanol) and the two immunosuppressive dru
gs cyclosporin A and FK 506. Lithium and propranolol were able to incr
ease the p-tyr level after 15 min in PHA-stimulated T cells from psori
atics in contrast to controls. Chloroquine and ethanol did not have a
significant effect on T cells of both groups. CsA markedly diminished
the phosphorylation of intracellular tyrosines in T cells of psoriatic
s and controls, whereas FK 506 diminished the p-tyr level in controls
only slightly. Conclusion: We have characterized important differences
in p-tyr phosphorylation activities of psoriatic T cells compared to
controls. This could be a hint to explain the known abnormalities of p
soriatic T cells.